garcinol and Lymphoma, Primary Effusion

garcinol has been researched along with Lymphoma, Primary Effusion in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cai, Q; Ding, L; Fu, W; Pan, C; Qian, Z; Tan, H; Wang, Y; Wei, F; Xu, H; Xu, W; Yuan, Z; Zhang, H; Zhou, F; Zhu, C; Zhu, Q	1

Other Studies

1 other study(ies) available for garcinol and Lymphoma, Primary Effusion

Article	Year
Identification of viral SIM-SUMO2-interaction inhibitors for treating primary effusion lymphoma. PLoS pathogens, 2019, Volume: 15, Issue:12 Topics: Animals; Antigens, Viral; Antineoplastic Agents; HEK293 Cells; Herpesviridae Infections; Herpesvirus 8, Human; Humans; Lymphoma, Primary Effusion; Mice; Nuclear Proteins; Plant Extracts; Small Ubiquitin-Related Modifier Proteins; Terpenes; Virus Latency; Xenograft Model Antitumor Assays	2019

Article

Year

Identification of viral SIM-SUMO2-interaction inhibitors for treating primary effusion lymphoma.

PLoS pathogens, 2019, Volume: 15, Issue:12

Topics: Animals; Antigens, Viral; Antineoplastic Agents; HEK293 Cells; Herpesviridae Infections; Herpesvirus 8, Human; Humans; Lymphoma, Primary Effusion; Mice; Nuclear Proteins; Plant Extracts; Small Ubiquitin-Related Modifier Proteins; Terpenes; Virus Latency; Xenograft Model Antitumor Assays

2019